Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors

Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors

Objectives: Increasing antimicrobial resistance rates limit empirical antimicrobial treatment options for Gram-negative bloodstream infections (GN-BSI). However, antimicrobial resistance may be predicted based on patient-specific risk factors using precision medicine concepts. This retrospective, 1:...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Majdi N. Al-Hasan, Alyssa P. Gould, Chelsea Drennan, Olivia Hill, Julie Ann Justo, Joseph Kohn, P. Brandon Bookstaver
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Elsevier 2020-09-01
Saila:Journal of Global Antimicrobial Resistance
Gaiak:
Bacteraemia
Sepsis
Enterobacteriaceae
Escherichia coli
Penicillins
Cephalosporins
Sarrera elektronikoa:http://www.sciencedirect.com/science/article/pii/S2213716519303297

Internet

http://www.sciencedirect.com/science/article/pii/S2213716519303297

Antzeko izenburuak